Results 151 to 160 of about 533,230 (332)

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

The FEBS Journal, EarlyView.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule   +4 more
wiley   +1 more source

ELECTROMYOGRAPHICAL STUDIES ON RESPIRATORY MUSCLES IN BRONCHIAL ASTHMA

, 1959
Ichiro Ikebe
openalex   +2 more sources

Angiogenesis in bronchial asthma

International Journal of Immunopathology and Pharmacology, 2015
K. Pałgan, Z. Bartuzi
semanticscholar   +1 more source

High Airway‐To‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD

Respirology, EarlyView.
This study demonstrated the association between an unbalanced volume ratio of airway to pulmonary blood vessels and shorter time to the first exacerbation in patients with chronic obstructive pulmonary disease, complementary to the presence of visually diagnosed bronchiectasis.
Nobuyasu Wakazono, Kaoruko Shimizu, Naoya Tanabe, Akira Oguma, Hironi Makita, Kazufumi Okada, Miho Wakazono, Hiroki Nishimura, Yuichi Kojima, Michiko Takimoto‐Sato, Munehiro Matsumoto, Yuki Abe, Ayako Igarashi‐Sugimoto, Nozomu Takei, Hirokazu Kimura, Houman Goudarzi, Takeshi Hattori, Ichizo Tsujino, Susumu Sato, Shigeo Muro, Masaharu Nishimura, Toyohiro Hirai, Satoshi Konno   +22 more
wiley   +1 more source

Endoscopic Observation in the Bronchial Asthma

, 1958
S. Yasui
openalex   +2 more sources

Biodegradable Stents—A New Option for Benign Central Airway Stenosis

Respirology, EarlyView.
Airway stenting using conventional stents for benign central airway stenosis has considerable complication rates as well as technical difficulties while placing and removing. Polydioxanone biodegradable stents serve as a feasible alternative for individuals requiring temporary airway support.
Oğuz Karcıoğlu, Eda Burcu Boerner, Faustina Funke, Jane Winantea, Filiz Oezkan, Rudiger Karpf‐Wissel, Kaid Darwiche   +6 more
wiley   +1 more source

Tracheobronchial Tuberculosis During Treatment for Bronchial Asthma. [PDF]

Respirol Case Rep
Sakai H, Tokuyasu H, Matsuoka S, Arai K, Esumi C, Yamasaki A.   +5 more
europepmc   +1 more source

Comparative evaluation of some methods of bronchial asthma treatment

, 1957
Ya. M. Grinberg, M. I. Lizunova, I. M. Smirnov   +2 more
openalex   +2 more sources

Inhaled Ciclesonide for Community‐Based COVID‐19: A Placebo‐Controlled Randomised Trial

Respirology, EarlyView.
We undertook a double‐blind, placebo‐controlled, randomised community trial of inhaled ciclesonide 320 mcg daily or placebo for 14 days. The primary outcome was time to recovery of symptoms to day 28. There were 189 people randomised and 185 completed treatment; 96% were COVID‐19 vaccinated.
Peter Wark, Ian C. Marschner, Owen Hutchings, Gemma Blunt, Greg J. Fox, Meg Jardine, Thomas Snelling, Arlen Wilcox, Emily Amico, Karen Allison, Kate Wilson, John Simes, Guy B. Marks   +12 more
wiley   +1 more source

Impact of severity of bronchial asthma on oral health in children. [PDF]

Front Oral Health
Alrashdi M, Alyahya A.
europepmc   +1 more source